DISEASE-MODIFYING ANTIRHEUMATIC DRUGS

You have access
Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis
Nicolino Ruperto, Hermine I. Brunner, Nikolay Tzaribachev, Gabriel Vega-Cornejo, Ingrid Louw, Rolando Cimaz, Jason Dare, Graciela Espada, Enrique Faugier, Manuel Ferrandiz, Valeria Gerloni, Pierre Quartier, Clovis Artur Silva, Linda Wagner-Weiner, Yash Gandhi, Julie Passarell, Marleen Nys, Robert Wong, Alberto Martini and Daniel J. Lovell for the Pediatric Rheumatology Collaborative Study Group (PRCSG) and the Paediatric Rheumatology International Trials Organisation (PRINTO)

The Journal of Rheumatology July 1 2021, 48 (7) 1073-1081; DOI: https://doi.org/10.3899/jrheum.200154
You have access
Relationship Between Depression and Disease Activity in United States Veterans With Early Rheumatoid Arthritis Receiving Methotrexate
Alan M. Rathbun, Bryant R. England, Ted R. Mikuls, Alice S. Ryan, Jennifer L. Barton, Michelle D. Shardell and Marc C. Hochberg

The Journal of Rheumatology June 1 2021, 48 (6) 813-820; DOI: https://doi.org/10.3899/jrheum.200743
You have access
Effect on Costs and Quality-adjusted Life-years of Treat-to-target Treatment Strategies Initiating Methotrexate, or Tocilizumab, or Their Combination in Early Rheumatoid Arthritis
Maxime M.A. Verhoeven, Janneke Tekstra, Jacob M. van Laar, Attila Pethö-Schramm, Michelle E.A. Borm, Johannes W.J. Bijlsma, Johannes W.G. Jacobs, Floris P.J.G. Lafeber and Paco M.J. Welsing

The Journal of Rheumatology April 1 2021, 48 (4) 495-503; DOI: https://doi.org/10.3899/jrheum.200067
You have access
Improving Hydroxychloroquine Dosing and Toxicity Screening at a Tertiary Care Ambulatory Center: A Quality Improvement Initiative
Sahil Koppikar, Stephanie Gottheil, Chandra Farrer and Natasha Gakhal

The Journal of Rheumatology January 1 2021, 48 (1) 138-144; DOI: https://doi.org/10.3899/jrheum.191265
You have access
Reasons for Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drug Cessation and Persistence of Second-line Treatment in a Rheumatoid Arthritis Dataset
Peter Youssef, Bruno Marcal, Peter Button, Matt Truman, Paul Bird, Hedley Griffiths, Lynden Roberts, Kathleen Tymms and Geoff Littlejohn

The Journal of Rheumatology August 1 2020, 47 (8) 1174-1181; DOI: https://doi.org/10.3899/jrheum.190535
You have access
Correlates of Successful Rheumatoid Arthritis Flare Management: Clinician-driven Treatment, Home-based Strategies, and Medication Change
Taysir G. Mahmoud, Jie Huang, Michelle Frits, Christine Iannaccone, Vivian Bykerk, Clifton O. Bingham III, Michael Weinblatt and Nancy A. Shadick

The Journal of Rheumatology March 1 2020, 47 (3) 333-340; DOI: https://doi.org/10.3899/jrheum.181160
You have access
Patient Preferences for Disease-modifying Antirheumatic Drug Treatment in Rheumatoid Arthritis: A Systematic Review
Caylib Durand, Maysoon Eldoma, Deborah A. Marshall, Nick Bansback and Glen S. Hazlewood

The Journal of Rheumatology February 1 2020, 47 (2) 176-187; DOI: https://doi.org/10.3899/jrheum.181165
Open Access
Effects of Sarilumab on Rheumatoid Arthritis as Reported by Patients Using the Rheumatoid Arthritis Impact of Disease Scale
Laure Gossec, Vibeke Strand, Clare Proudfoot, Chieh-I Chen, Sophie Guillonneau, Toshio Kimura, Hubert van Hoogstraten, Erin Mangan and Matthew Reaney

The Journal of Rheumatology October 1 2019, 46 (10) 1259-1267; DOI: https://doi.org/10.3899/jrheum.180904
You have access
Patient Perspectives on DMARD Safety Concerns in Rheumatology Trials: Results from Inflammatory Arthritis Patient Focus Groups and OMERACT Attendees Discussion
Kathleen M. Andersen, Ayano Kelly, Anne Lyddiatt, Clifton O. Bingham III, Vivian P. Bykerk, Adena Batterman, Joan Westreich, Michelle K. Jones, Marita Cross, Peter M. Brooks, Lyn March, Beverley Shea, Peter Tugwell, Lee S. Simon, Robin Christensen and Susan J. Bartlett

The Journal of Rheumatology September 1 2019, 46 (9) 1168-1172; DOI: https://doi.org/10.3899/jrheum.181185
You have access
Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials
Kathleen M. Andersen, Jonathan T.L. Cheah, Lyn March, Susan J. Bartlett, Dorcas Beaton, Clifton O. Bingham III, Peter M. Brooks, Robin Christensen, Philip G. Conaghan, Maria-Antonietta D’Agostino, Maarten de Wit, Amylou C. Dueck, Susan M. Goodman, Shawna Grosskleg, Catherine L. Hill, Martin Howell, Sarah L. Mackie, Bethan Richards, Beverly Shea, Jasvinder A. Singh, Vibeke Strand, Peter Tugwell, George A. Wells and Lee S. Simon

The Journal of Rheumatology August 1 2019, 46 (8) 1053-1058; DOI: https://doi.org/10.3899/jrheum.181123

Main menu

User menu

Search

DISEASE-MODIFYING ANTIRHEUMATIC DRUGS

Pages

Content

Resources

Subscribers

More